Sells medical cannabis products to patients in Israel and Germany.
Dec 2025Revenue C$54.7M/yrExpenses C$66.3M/yr
No trend
Figures by year
When will IM Cannabis be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was C$54.7M and expenses C$66.3M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | C$54.7M | C$66.3M | −C$11.6M |
| Dec 2024 | C$54.0M | C$64.3M | −C$10.2M |
| Dec 2023 | C$48.8M | C$61.6M | −C$12.8M |
| Dec 2022 | C$54.3M | C$85.1M | −C$30.8M |
| Dec 2021 | C$34.1M | C$57.1M | −C$23.0M |
| Dec 2020 | C$15.9M | C$24.1M | −C$8.24M |
| Dec 2019 | C$9.07M | C$19.3M | −C$10.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.